ClinicalTrials.gov
public full text
Public Domain
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
The primary objective of the study is to demonstrate the efficacy of SPD489 compared with placebo in adults (18 55 years of age inclusive) with moderate to severe Binge Eating Disorder at Visit 8 (Weeks 11 and 12) as measured by the number of binge days (defined as days during which at least 1 binge episode occurs) per week as assessed by clinical interview based on subject diary
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder#1339927
- Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity#807760
- Atomoxetine in the Treatment of Binge Eating Disorder#828597
- Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder#856725
- Implementing Supported Digital Enhanced Cognitive Behavior Therapy for Binge Eating Disorder in Routine Care: Mixed Methods Service Evaluation.#422847
Record · ID 1477831
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive